Effect of preventing coronary artery disease multimedia software on adjusting risk factors in patients with heart disease

Effect of preventing coronary artery disease multimedia software on adjusting risk factors in patients with coronary artery disease

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017072220833N3

Enrollment

Registered

2017-11-19

Start date

2016-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease. Diseases of arteries, arterioles and capillaries

Interventions

32 patients will be selected randomly based on inclusion criteria then demographic questionnaire will be filled and multimedia software of coronary artery disease will be given to the patients in the

Prevention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Acute Coronary Syndrome(acute myocardial infarction with elevated ST segment, myocardial infarction without ST elevation and unstable angina); having computer at home; willingness for participating in the study; being oriented of their disease; knowing Persian language; not having mental retardation, disabilities, blindness, Deafness and active psychological disease; not having thyroid and digestive disease; not having complications of acute coronary syndrome like acute pulmonary edema and congestive heart disease. Exclusion criteria: unwillingness for participating in the study and filling questionnaires incompletely.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: before the intervention and three month after the intervention. Method of measurement: Mercury barometric.;Blood Triglyceride. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Low-density lipoprotein(LDL). Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;High-density lipoprotein(HDL). Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Cholesterol. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Fasting blood sugar. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.	—

Measure

Time frame

Blood pressure. Timepoint: before the intervention and three month after the intervention. Method of measurement: Mercury barometric.;Blood Triglyceride. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Low-density lipoprotein(LDL). Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;High-density lipoprotein(HDL). Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Cholesterol. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Fasting blood sugar. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahin Moeini

Isfahan University Of Medical Sciences

moeini@nm.mui.ac.ir+98 31 3792 7621

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026